文献速递艾滋病与性传播感染新发突发、热带与寄生虫病

HIV感染者免疫缺陷与癌症关联:南非HIV癌症匹配研究

Immunodeficiency and Cancer in 3.5 Million People Living With Human Immunodeficiency Virus (HIV): The South African HIV Cancer Match Study.
PubMed 文献 · Clin Infect Dis · 2021-01-01

采用Cox比例风险模型分析时间更新CD4计数与癌症发病率的关系,发现较低CD4计数与多种感染相关癌症风险升高相关。

要点

  • CD4每降低100个/µL,结膜癌风险aHR 1.46,卡波西肉瘤aHR 1.23,非霍奇金淋巴瘤aHR 1.18。
  • 感染无关癌症中,仅食管癌与低CD4相关(aHR 1.06),乳腺癌、肺癌、前列腺癌无关联。
  • 减少HIV所致免疫缺陷可能是撒哈拉以南非洲HIV感染者的有效癌症预防策略。

核心结论

  • 较低CD4细胞计数与HIV感染者多种感染相关癌症风险升高相关。
  • 减少HIV诱导的免疫缺陷可能是撒哈拉以南非洲HIV感染者的有力癌症预防策略。

研究设计与样本

  • 研究基于南非HIV癌症匹配研究,链接国家卫生实验室服务的HIV相关实验室检测数据与国家癌症登记处的癌症记录。
  • 采用Cox比例风险模型评估时间更新CD4细胞计数与癌症发病率的关系,报告调整风险比(aHR)及每降低100个CD4细胞/µL的aHR。

主要发现

  • 最常见癌症为宫颈癌(4150例)、卡波西肉瘤(2262例)和非霍奇金淋巴瘤(1060例)。
  • CD4降低与癌症发病率关联最强的是结膜癌(每100个/µL aHR 1.46;95%CI 1.38-1.54)、卡波西肉瘤(aHR 1.23;95%CI 1.20-1.26)和非霍奇金淋巴瘤(aHR 1.18;95%CI 1.14-1.22)。
  • 感染无关癌症中,较低CD4与食管癌发病率升高相关(aHR 1.06;95%CI 1.00-1.11),但与乳腺癌、肺癌、前列腺癌无关。

临床怎么用

  • 对于HIV感染者,应重视CD4细胞计数监测,低CD4水平提示感染相关癌症风险增高。
  • 优化HIV治疗以维持或提升CD4计数,可能有助于降低感染相关癌症的发生风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We analyzed associations between immunodeficiency and cancer incidence in a nationwide cohort of people living with human immunodeficiency virus (HIV; PLWH) in South Africa. METHODS: We used data from the South African HIV Cancer Match Study built on HIV-related laboratory measurements from the National Health Laboratory Services and cancer records from the National Cancer Registry. We evaluated associations between time-updated CD4 cell count and cancer incidence rates using Cox proportional hazards models. We reported adjusted hazard ratios (aHRs) over a grid of CD4 values and estimated the aHR per 100 CD4 cells/µL decrease. RESULTS: Of 3 532 266 PLWH, 15 078 developed cancer. The most common cancers were cervical cancer (4150 cases), Kaposi sarcoma (2262 cases), and non-Hodgkin lymphoma (1060 cases). The association between lower CD4 cell count and higher cancer incidence rates was strongest for conjunctival cancer (aHR per 100 CD4 cells/µL decrease: 1.46; 95% confidence interval [CI], 1.38-1.54), Kaposi sarcoma (aHR, 1.23; 95% CI, 1.20-1.26), and non-Hodgkin lymphoma (aHR, 1.18; 95% CI, 1.14-1.22). Among infection-unrelated cancers, lower CD4 cell counts were associated with higher incidence rates of esophageal cancer (aHR, 1.06; 95% CI, 1.00-1.11) but not breast, lung, or prostate cancer. CONCLUSIONS: Lower CD4 cell counts were associated with an increased risk of developing various infection-related cancers among PLWH. Reducing HIV-induced immunodeficiency may be a potent cancer-prevention strategy among PLWH in sub-Saharan Africa, a region heavily burdened by cancers attributable to infections.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Ruffieux Y, Muchengeti M, Egger M, et al. Immunodeficiency and Cancer in 3.5 Million People Living With Human Immunodeficiency Virus (HIV): The South African HIV Cancer Match Study. Clin Infect Dis. 2021. PMID: 33530095. doi:10.1093/cid/ciab087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。